Client Advisor Employee
Username
Password
  • Mutual Funds

    When it comes to the world of investing, three words come to mind: overwhelming, intimidating, and scary.

  • Financial Planning

    In finance, investment is putting money into an asset with the expectation of capital appreciation.

  • Time for changes

    Bottoms in the investment world don't end with four-year lows; they end with 10- or 15-year lows.

  • Solution

    The stock market is filled with individuals who know the price of everything, but the value of nothing.

Welcome To My Money Manager



"You Work Hard For Money
We Work Harder For You
It Makes Your Money Working For You"
Sunil Verma
PRACTICE HEAD
My Money Manager is a personal finance service provider to individuals and corporates. We are in business of advising, executing and managing portfolio within carefully designed process framework in order to build wealth and save money for our customers. We act as the single-point service provider where all financial, investment and tax planning services are offered under one roof. The company has strong leadership team with a history of entrepreneurial and management success.
To be the most trusted and leading provider of independent financial advisory service and to provide best and prompt services to our investors. We guide our clients to achieve financial freedom and get a healthy financial well-being for rest of their life. We treat our investor with respect and provide them with numerous opportunities to learn and grow. Our Client's financial success is our top priority.
Read More

e - learning
Fund Performance
Market Watch
  • MF News
  • IPO News

Neogen Chemicals IPO to open on April 24; here#39;s all you need to know Neogen Chemicals (NCL) is manufacturers of bromine-based, and lithium-based, specialty chemicals
Tue, 23 Apr 2019 08:58:18 +0530


Avoid Neogen Chemicals: Choice Broking Choice Broking has come out with its report on Neogen Chemicals. The research firm has recommended to "Avoid#39;#39; the IPO in its research report as on April 22, 2019
Mon, 22 Apr 2019 14:00:00 +0530


Avoid Neogen Chemicals: Choice Broking Choice Broking has come out with its report on Neogen Chemicals. The research firm has recommended to "Avoid#39;#39; the IPO in its research report as on April 22, 2019
Mon, 22 Apr 2019 14:00:00 +0530


Bumper Listing: Polycab India debuts with 18% premium at Rs 638 The Rs 1,345-crore public issue saw a massive subscription of 51.96 times during April 5-9, 2019
Tue, 16 Apr 2019 10:00:50 +0530


Metropolis Healthcare ends at Rs 959.85, a 9% premium over issue price Metropolis Healthcare#39;s market valuation was at Rs 4,814.90 crore on the BSE
Mon, 15 Apr 2019 16:34:19 +0530


Good Listing: Metropolis Healthcare debuts with 9% premium at Rs 960 The stock opened with a 9 percent premium over its issue price of Rs 880 while on the National Stock Exchange it opened at Rs 958.
Mon, 15 Apr 2019 10:07:37 +0530


Rail Vikas Nigam closes marginally higher at Rs 19.05 on Day 1 RVNL#39;s Rs 480 crore initial public offer was opened for subscription earlier this month with a price band at Rs 17-19 per share and was subscribed 1.8 times.
Thu, 11 Apr 2019 17:50:30 +0530


Rail Vikas Nigam debuts flat at Rs 19 on NSE, BSE The company raised about Rs 480 crore by selling 12.12 percent stake
Thu, 11 Apr 2019 10:10:35 +0530


Polycab India IPO oversubscribed 52 times on good response from institutional investors The issue was opened for subscription on April 5, with a price band at Rs 533-538 per share.
Tue, 09 Apr 2019 20:12:25 +0530


Subscribe to Polycab India: Geojit Financial Geojit Financial has come out with its report on Polycab India. The research firm has recommended to "Subscribe" the IPO in its research report as on April 04, 2019
Tue, 09 Apr 2019 12:04:26 +0530


Subscribe to Polycab India: Choice Broking Choice Broking has come out with its report on Polycab India. The research firm has recommended to "Subscribe" the IPO in its research report as on April 04, 2019
Tue, 09 Apr 2019 11:49:44 +0530


Polycab India IPO subscribed 1.18 times Price range for the offer, which is scheduled to close Tuesday, has been fixed at Rs 533-538 per share.
Mon, 08 Apr 2019 15:40:05 +0530


Subscribe to Polycab India: Prabhudas Lilladher Prabhudas Lilladher has come out with its report on Polycab India. The research firm has recommended to "Subscribe" the IPO in its research report as on April 04, 2019
Mon, 08 Apr 2019 11:37:32 +0530


Subscribe to Polycab India: Mehta Equities Mehta Equities has come out with its report on Polycab India. The research firm has recommended to "Subscribe" the IPO in its research report as on April 04, 2019
Mon, 08 Apr 2019 11:32:35 +0530


Metropolis Healthcare IPO oversubscribed 5.84 times on interest from QIB The reserved portion for qualified institutional investors has seen subscription of 8.88 times and non-institutional investors 3.03 times while retail investors part is subscribed 2.21 times.
Fri, 05 Apr 2019 22:02:53 +0530